KRISTY LOFTIS: Open Payments
NPI 1811758543 · HUDSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 52 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $388 · 2025 $955
Food & beverage: $955
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $192 |
| PFIZER INC. | 6 | $142 |
| AstraZeneca Pharmaceuticals LP | 7 | $117 |
| Novo Nordisk Inc | 5 | $88 |
| GlaxoSmithKline, LLC. | 3 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Abbott Laboratories | 3 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Exact Sciences Corporation | 2 | $35 |
| Organon LLC | 2 | $33 |
Products named: VRAYLAR, ELIQUIS, AIRSUPRA, TRELEGY ELLIPTA, CAPLYTA, Ozempic, FREESTYLE LIBRE 3, XIFAXAN.
Industry payments across NC — which companies pay providers there.
